carmustine has been researched along with alvocidib in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bible, KC; Kaufmann, SH | 1 |
Anderl, KL; Bartelt, D; Bible, KC; Boerner, SA; Eckdahl, S; Jenkins, RB; Kaufmann, SH; Kirkland, K; Kottke, TJ; Lee, YK; Stalboerger, PG; Svingen, PA | 1 |
4 other study(ies) available for carmustine and alvocidib
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carmustine; Cisplatin; Cyclin-Dependent Kinases; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Synergism; Etoposide; Flavonoids; Fluorouracil; Humans; Lung Neoplasms; Paclitaxel; Piperidines; Tumor Stem Cell Assay | 1997 |
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
Topics: Antineoplastic Agents; Carmustine; Chromosome Aberrations; Chromosome Mapping; Cisplatin; DNA Adducts; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Karyotyping; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Piperidines; Tumor Cells, Cultured | 2000 |